Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Israel said…
Sam Bankman-Fried’s fate is now officially in the hands of a jury of his peers. Over the past four weeks in a…
Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. AP Møller-Maersk…
Walgreens is cancelling corporate bonuses as big pharmacies face increasing difficulties
By Press Room
4 Mins read
As financial pressures mount on Walgreens, the nation’s largest drugstore chain, the company said it will cancel bonuses this year for its…
Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Shareholders in…
Blockbuster weight-loss drugs boost pharmaceutical companies Novo Nordisk and Eli Lilly
By Press Room
1 Mins read
As prescriptions for weight-loss and diabetes drugs skyrocket, so too has revenue for drugmakers Novo Nordisk and Eli Lilly. On Thursday, Novo…
Stay informed with free updates Simply sign up to the Private equity myFT Digest — delivered directly to your inbox. The IMF…
The first United Auto Workers union vote by rank-and-file members was 82% in favor of the tentative labor deal that ended the…
Reporter Joshua Oliver joins us just hours after the closing arguments of the fraud trial of Sam Bankman-Fried, founder of the FTX…
White House calls on Fox News to apologize after top host’s ‘sickening’ Islamophobic rant
By Press Room
2 Mins read
Editor’s Note: A version of this article first appeared in the “Reliable Sources” newsletter. Sign up for the daily digest chronicling the evolving…